spacer gif spacer gif spacer gif spacer gif Propose a workshop for 2011 spacer gif
 QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    


This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Milligan, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Milligan, G.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Journal of Cell Science, Vol 114, Issue 7 1265-1271, Copyright © 2001 by Company of Biologists


JOURNAL ARTICLES

Oligomerisation of G-protein-coupled receptors

G Milligan
Molecular Pharmacology Group, Division of Biochemistry and Molecular Biology, Institute of Biomedical and Life Sciences, University of Glasgow, Glasgow, G12 8QQ, UK.

A range of approaches have recently provided evidence that G-protein-coupled receptors can exist as oligomeric complexes. Both homo-oligomers, comprising multiple copies of the same gene product, and hetero-oligomers containing more than one receptor have been detected. In several, but not all, examples, the extent of oligomerisation is regulated by the presence of agonist ligands, and emerging evidence indicates that receptor hetero-oligomers can display distinct pharmacological characteristics. A chaperonin-like role for receptor oligomerisation in effective delivery of newly synthesised receptors to the cell surface is a developing concept, and recent studies have employed a series of energy-transfer techniques to explore the presence and regulation of receptor oligomerisation in living cells. However, the majority of studies have relied largely on co-immunoprecipitation techniques, and there is still little direct information on the fraction of receptors existing as oligomers in intact cells.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
D. S. Redka, L. F. Pisterzi, and J. W. Wells
Binding of Orthosteric Ligands to the Allosteric Site of the M2 Muscarinic Cholinergic Receptor
Mol. Pharmacol., September 1, 2008; 74(3): 834 - 843.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
P. S.-H. Park and K. Palczewski
Diversifying the repertoire of G protein-coupled receptors through oligomerization
PNAS, June 21, 2005; 102(25): 8793 - 8794.
[Full Text] [PDF]


Home page
CirculationHome page
E. Kostenis, G. Milligan, A. Christopoulos, C. F. Sanchez-Ferrer, S. Heringer-Walther, P. M. Sexton, F. Gembardt, E. Kellett, L. Martini, P. Vanderheyden, et al.
G-Protein-Coupled Receptor Mas Is a Physiological Antagonist of the Angiotensin II Type 1 Receptor
Circulation, April 12, 2005; 111(14): 1806 - 1813.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
T. T. Cao, A. Brelot, and M. von Zastrow
The Composition of the {beta}-2 Adrenergic Receptor Oligomer Affects Its Membrane Trafficking after Ligand-Induced Endocytosis
Mol. Pharmacol., January 1, 2005; 67(1): 288 - 297.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Mesnier and J.-L. Baneres
Cooperative Conformational Changes in a G-protein-coupled Receptor Dimer, the Leukotriene B4 Receptor BLT1
J. Biol. Chem., November 26, 2004; 279(48): 49664 - 49670.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
R. A. Bakker, G. Dees, J. J. Carrillo, R. G. Booth, J. F. Lopez-Gimenez, G. Milligan, P. G. Strange, and R. Leurs
Domain Swapping in the Human Histamine H1 Receptor
J. Pharmacol. Exp. Ther., October 1, 2004; 311(1): 131 - 138.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Suzuki, E. Moriyoshi, D. Tsuchiya, and H. Jingami
Negative Cooperativity of Glutamate Binding in the Dimeric Metabotropic Glutamate Receptor Subtype 1
J. Biol. Chem., August 20, 2004; 279(34): 35526 - 35534.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
D. Ramsay, I. C. Carr, J. Pediani, J. F. Lopez-Gimenez, R. Thurlow, M. Fidock, and G. Milligan
High-Affinity Interactions between Human {alpha}1A-Adrenoceptor C-Terminal Splice Variants Produce Homo- and Heterodimers but Do Not Generate the {alpha}1L-Adrenoceptor
Mol. Pharmacol., August 1, 2004; 66(2): 228 - 239.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Breit, M. Lagace, and M. Bouvier
Hetero-oligomerization between {beta}2- and {beta}3-Adrenergic Receptors Generates a {beta}-Adrenergic Signaling Unit with Distinct Functional Properties
J. Biol. Chem., July 2, 2004; 279(27): 28756 - 28765.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
X. Shi, B. Gangadharan, L. F. Brass, W. Ruf, and B. M. Mueller
Protease-Activated Receptors (PAR1 and PAR2) Contribute to Tumor Cell Motility and Metastasis
Mol. Cancer Res., July 1, 2004; 2(7): 395 - 402.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. Pivonello, C. Matrone, M. Filippella, L. M. Cavallo, C. Di Somma, P. Cappabianca, A. Colao, L. Annunziato, and G. Lombardi
Dopamine Receptor Expression and Function in Clinically Nonfunctioning Pituitary Tumors: Comparison with the Effectiveness of Cabergoline Treatment
J. Clin. Endocrinol. Metab., April 1, 2004; 89(4): 1674 - 1683.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
G. E. Breitwieser
G Protein-Coupled Receptor Oligomerization: Implications for G Protein Activation and Cell Signaling
Circ. Res., January 9, 2004; 94(1): 17 - 27.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Pfeiffer, S. Kirscht, R. Stumm, T. Koch, D. Wu, M. Laugsch, H. Schroder, V. Hollt, and S. Schulz
Heterodimerization of Substance P and {micro}-Opioid Receptors Regulates Receptor Trafficking and Resensitization
J. Biol. Chem., December 19, 2003; 278(51): 51630 - 51637.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. J. Carrillo, J. Pediani, and G. Milligan
Dimers of Class A G Protein-coupled Receptors Function via Agonist-mediated Trans-activation of Associated G Proteins
J. Biol. Chem., October 24, 2003; 278(43): 42578 - 42587.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
C. Carron, A. Pascal, A. Djiane, J.-C. Boucaut, D.-L. Shi, and M. Umbhauer
Frizzled receptor dimerization is sufficient to activate the Wnt/{beta}-catenin pathway
J. Cell Sci., June 15, 2003; 116(12): 2541 - 2550.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Chelli and M. Alizon
Rescue of HIV-1 Receptor Function through Cooperation between Different Forms of the CCR5 Chemokine Receptor
J. Biol. Chem., October 11, 2002; 277(42): 39388 - 39396.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C.-C. Zhu, L. B. Cook, and P. M. Hinkle
Dimerization and Phosphorylation of Thyrotropin-releasing Hormone Receptors Are Modulated by Agonist Stimulation
J. Biol. Chem., July 26, 2002; 277(31): 28228 - 28237.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
S. Azhar, A. Nomoto, and E. Reaven
Hormonal regulation of adrenal microvillar channel formation
J. Lipid Res., June 1, 2002; 43(6): 861 - 871.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. C. Patel, U. Kumar, D. C. Lamb, J. S. Eid, M. Rocheville, M. Grant, A. Rani, T. Hazlett, S. C. Patel, E. Gratton, et al.
Ligand binding to somatostatin receptors induces receptor-specific oligomer formation in live cells
PNAS, March 5, 2002; 99(5): 3294 - 3299.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Chelli and M. Alizon
Determinants of the trans-Dominant Negative Effect of Truncated Forms of the CCR5 Chemokine Receptor
J. Biol. Chem., December 7, 2001; 276(50): 46975 - 46982.
[Abstract] [Full Text] [PDF]


Home page
Mol. Interv.Home page
J. C. Bermak and Q.-Y. Zhou
Accessory Proteins in the Biogenesis of G Protein-Coupled Receptors
Mol. Interv., December 1, 2001; 1(5): 282 - 287.
[Abstract] [Full Text] [PDF]




© The Company of Biologists Ltd 2001